- Home
- CIK vs BDTX Comparison
CIK vs BDTX Comparison
Compare CIK & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIK
- BDTX
- Stock Information
- Founded
- CIK 1987
- BDTX 2014
- Country
- CIK United States
- BDTX United States
- Employees
- CIK N/A
- BDTX N/A
- Industry
- CIK Finance/Investors Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIK Finance
- BDTX Health Care
- Exchange
- CIK Nasdaq
- BDTX Nasdaq
- Market Cap
- CIK 162.5M
- BDTX 161.6M
- IPO Year
- CIK N/A
- BDTX 2020
- Fundamental
- Price
- CIK $3.00
- BDTX $2.52
- Analyst Decision
- CIK
- BDTX Strong Buy
- Analyst Count
- CIK 0
- BDTX 4
- Target Price
- CIK N/A
- BDTX $15.50
- AVG Volume (30 Days)
- CIK 115.4K
- BDTX 558.0K
- Earning Date
- CIK 01-01-0001
- BDTX 11-05-2024
- Dividend Yield
- CIK 9.03%
- BDTX N/A
- EPS Growth
- CIK N/A
- BDTX N/A
- EPS
- CIK N/A
- BDTX N/A
- Revenue
- CIK N/A
- BDTX N/A
- Revenue This Year
- CIK N/A
- BDTX N/A
- Revenue Next Year
- CIK N/A
- BDTX N/A
- P/E Ratio
- CIK N/A
- BDTX N/A
- Revenue Growth
- CIK N/A
- BDTX N/A
- 52 Week Low
- CIK $2.50
- BDTX $2.16
- 52 Week High
- CIK $3.19
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- CIK 51.81
- BDTX 29.57
- Support Level
- CIK $2.93
- BDTX $3.16
- Resistance Level
- CIK $2.99
- BDTX $3.44
- Average True Range (ATR)
- CIK 0.03
- BDTX 0.22
- MACD
- CIK 0.00
- BDTX -0.03
- Stochastic Oscillator
- CIK 87.50
- BDTX 10.62
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations, and individuals.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.